Neogenix, LLC
Country not established
- Devices
- 1
What Neogenix, LLC makes
Neogenix, LLC manufactures the EPIFLO®, a medical device designed for use in the management of epistaxis (nosebleeds), likely as a hemostatic agent or nasal packing system.
The EPIFLO® is classified as a Class II device under FDA regulations and is listed in the FDA’s 510(k) clearance registry. The company is based in the United States.
Catalogue
Epiflo(R) Ref K120764
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neogenix, LLC have in the registry?
The registry currently lists 1 device for Neogenix, LLC. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neogenix, LLC's devices?
Among its 1 most recently registered device, Neogenix, LLC has devices listed in FDA 510(k) (1 device).
What risk classes do Neogenix, LLC's devices fall under?
Among its 1 most recently registered device, the classes recorded for Neogenix, LLC's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neogenix, LLC in the registry?
The most recently registered devices listed for Neogenix, LLC include EPIFLO(R).